Gossypetin targets the liver-brain axis to alleviate pre-existing liver fibrosis and hippocampal neuroinflammation in mice.
Researchers found gossypetin, a compound from sedum, effectively treats liver fibrosis and related brain issues in mice. It targets liver-brain axis, reducing liver damage and neuroinflammation. Potential therapy for chronic liver patients with neurological symptoms.
- Xu C et al (2024).
- Front Pharmacol.
- PubMed:
- 38860164